1H-PYRAZOLO[4,3-C]PYRIDINE, 3-BROMO-4-CHLORO-, 95%, 1g

6-CHLORO-2-FLUORO-3-METHOXYBENZALDEHYDE, 97.0%, 25g

1-(2,5-dimethylphenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

2-Amino-5-bromo-3-pyridinol, 98.0%, 5g

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-acetyl-L-lysine>98.0%(HPLC)(T)1g

(Z)-5H-Cyclopenta[b]pyridin-7(6H)-one O-methyl oxime, 98.0%, 100mg

(S)-(-)-3-(N-Methylamino)-1-(2-thienyl)-1-propanol, 95.0%, 10g

Methyl 2-chloro-6-fluoroquinoline-4-carboxylate, 98%, 1g

(R)-3-N-Boc-Aminopiperidine, 98.0%, 1g

Potassium ((4-(tert-butoxycarbonyl)piperazin-1-yl)methyl)trifluoroborate, 95.0%, 250mg

Linsitinib, 5mg

Cyclopentylsulfonyl chloride, 95.0%, 1g

(R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-methanol, 95.0%, 500g